Latest Insider Transactions at Adapt Health Corp. (AHCO)
This section provides a real-time view of insider transactions for Adapt Health Corp. (AHCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AdaptHealth Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AdaptHealth Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2022
|
Sky Knight Capital Fund Ii, L.P. Director |
BUY
Open market or private purchase
|
Direct |
13,352
+0.54%
|
$200,280
$15.0 P/Share
|
|
Mar 03
2022
|
Stephen P Griggs Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
32,342
+0.9%
|
$485,130
$15.44 P/Share
|
|
Mar 02
2022
|
Jason A Clemens Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,590
+0.94%
|
$23,850
$15.69 P/Share
|
|
Feb 28
2022
|
Albert A. Prast Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
465
-0.5%
|
$7,905
$17.43 P/Share
|
|
Feb 28
2022
|
Frank Mullen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.72%
|
$2,601
$17.43 P/Share
|
|
Feb 16
2022
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
4,973
+2.18%
|
-
|
|
Feb 16
2022
|
Daniel Bunting |
BUY
Grant, award, or other acquisition
|
Direct |
4,973
+6.21%
|
-
|
|
Feb 16
2022
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,503
+3.77%
|
-
|
|
Feb 16
2022
|
Stephen P Griggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,650
+6.7%
|
-
|
|
Feb 16
2022
|
Christopher J Joyce General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,120
+5.52%
|
-
|
|
Feb 16
2022
|
Josh Parnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,650
+1.09%
|
-
|
|
Feb 16
2022
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+5.77%
|
-
|
|
Feb 01
2022
|
Daniel Bunting |
BUY
Grant, award, or other acquisition
|
Direct |
10,422
+12.94%
|
-
|
|
Feb 01
2022
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,670
+19.1%
|
-
|
|
Feb 01
2022
|
Stephen P Griggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,617
+45.22%
|
-
|
|
Feb 01
2022
|
Christopher J Joyce General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
28,880
+22.64%
|
-
|
|
Feb 01
2022
|
Josh Parnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,617
+10.52%
|
-
|
|
Feb 01
2022
|
Albert A. Prast Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,348
-3.67%
|
-
|
|
Feb 01
2022
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,113
+21.6%
|
-
|
|
Feb 01
2022
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
10,422
+4.56%
|
-
|
|
Jan 01
2022
|
Frank Mullen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-0.53%
|
-
|
|
Jan 01
2022
|
Albert A. Prast Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061
-1.58%
|
-
|
|
Jan 01
2022
|
Christopher J Joyce General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,744
-3.78%
|
-
|
|
Dec 31
2021
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
6,188
+2.89%
|
-
|
|
Dec 31
2021
|
Christopher J Joyce General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,367
-11.43%
|
-
|
|
Dec 31
2021
|
Christopher J Joyce General Counsel |
BUY
Grant, award, or other acquisition
|
Indirect |
6,873
+3.23%
|
-
|
|
Dec 31
2021
|
Josh Parnes Director |
SELL
Payment of exercise price or tax liability
|
Direct |
25,576
-4.01%
|
-
|
|
Dec 01
2021
|
Jason A Clemens Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,300
+1.06%
|
$24,700
$19.77 P/Share
|
|
Nov 30
2021
|
Stephen P Griggs Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.39%
|
$950,000
$19.42 P/Share
|
|
Oct 11
2021
|
Josh Parnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,258
+2.03%
|
-
|
|
Oct 11
2021
|
Stephen P Griggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,258
+43.45%
|
-
|
|
Oct 11
2021
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,359
+25.08%
|
-
|
|
Oct 11
2021
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,364
+8.66%
|
-
|
|
Oct 11
2021
|
Daniel Bunting |
BUY
Grant, award, or other acquisition
|
Direct |
955
+1.58%
|
-
|
|
Oct 11
2021
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
955
+0.47%
|
-
|
|
Oct 11
2021
|
Christopher J Joyce General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,834
+6.65%
|
-
|
|
Sep 30
2021
|
Gregory Belinfanti Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,509
+50.0%
|
-
|
|
Sep 23
2021
|
Frank Mullen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
945
-4.22%
|
$21,735
$23.52 P/Share
|
|
Aug 23
2021
|
Terence J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,509
+24.34%
|
-
|
|
Aug 23
2021
|
Theodore B. Lundberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,509
+50.0%
|
-
|
|
Aug 23
2021
|
Bradley J Coppens Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,509
+33.33%
|
-
|
|
Aug 23
2021
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,635
+14.72%
|
-
|
|
Aug 23
2021
|
David Solomon Williams Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,509
+33.33%
|
-
|
|
Aug 23
2021
|
Susan T Weaver Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,509
+12.16%
|
-
|
|
Aug 23
2021
|
Richard A Barasch Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,017
+2.59%
|
-
|
|
Aug 20
2021
|
Shaw Rietkerk |
SELL
Open market or private sale
|
Direct |
49,443
-19.77%
|
$1,137,189
$23.16 P/Share
|
|
Aug 04
2021
|
Josh Parnes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
416,666
+39.99%
|
$4,583,326
$11.5 P/Share
|
|
May 20
2021
|
Frank Mullen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,650
+25.47%
|
-
|
|
May 20
2021
|
Stephen P Griggs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$96,000
$24.14 P/Share
|
|
May 17
2021
|
Dale B Wolf Director |
BUY
Open market or private purchase
|
Indirect |
7,000
+33.33%
|
$168,000
$24.78 P/Share
|